Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Profitability Ratios
Quarterly Data

Microsoft Excel

Profitability Ratios (Summary)

Baxter International Inc., profitability ratios (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Return on Sales
Gross profit margin 40.23% 41.17% 41.59% 44.76% 46.78% 47.85% 48.93% 47.61% 48.07% 49.36% 49.77% 51.53% 51.65% 51.53% 51.45% 51.04% 50.75% 50.62% 50.72%
Operating profit margin 5.23% 5.48% 4.50% 9.03% 11.48% 13.97% 16.24% 14.26% 15.21% 16.76% 17.48% 19.05% 20.17% 19.95% 19.88% 20.47% 20.24% 20.68% 21.20%
Net profit margin 47.74% 39.42% 9.71% 14.50% 16.11% 15.57% 14.98% 11.29% 12.05% 12.87% 13.19% 14.89% 15.47% 16.07% 16.39% 16.36% 16.30% 16.02% 16.01%
Return on Investment
Return on equity (ROE) 56.39% 43.44% 10.94% 21.93% 27.33% 32.67% 30.75% 22.25% 22.47% 23.25% 23.77% 28.13% 30.47% 32.90% 33.53% 32.19% 34.93% 33.34% 33.77%
Return on assets (ROA) 30.02% 22.58% 4.62% 8.51% 7.27% 9.54% 9.63% 7.32% 7.59% 7.98% 7.78% 8.63% 9.34% 11.27% 11.41% 11.58% 12.40% 11.94% 11.66%

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Baxter International Inc. gross profit margin ratio deteriorated from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Baxter International Inc. operating profit margin ratio improved from Q4 2015 to Q1 2016 but then slightly deteriorated from Q1 2016 to Q2 2016.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Baxter International Inc. net profit margin ratio improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Baxter International Inc. ROE improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.
ROA A profitability ratio calculated as net income divided by total assets. Baxter International Inc. ROA improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.

Gross Profit Margin

Baxter International Inc., gross profit margin calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Gross margin 972 965 1,072 1,034 1,021 1,019 2,224 2,073 1,969 1,891 1,954 1,946 1,939 1,756 1,905 1,810 1,872 1,714 1,765 1,771 1,835 1,675
Net sales 2,585 2,375 2,603 2,487 2,475 2,403 4,472 4,197 4,154 3,848 4,368 3,774 3,669 3,448 3,753 3,477 3,572 3,388 3,594 3,479 3,536 3,284
Profitability Ratio
Gross profit margin1 40.23% 41.17% 41.59% 44.76% 46.78% 47.85% 48.93% 47.61% 48.07% 49.36% 49.77% 51.53% 51.65% 51.53% 51.45% 51.04% 50.75% 50.62% 50.72%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
Gross profit margin = 100 × (Gross marginQ2 2016 + Gross marginQ1 2016 + Gross marginQ4 2015 + Gross marginQ3 2015) ÷ (Net salesQ2 2016 + Net salesQ1 2016 + Net salesQ4 2015 + Net salesQ3 2015)
= 100 × (972 + 965 + 1,072 + 1,034) ÷ (2,585 + 2,375 + 2,603 + 2,487) = 40.23%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Baxter International Inc. gross profit margin ratio deteriorated from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.

Operating Profit Margin

Baxter International Inc., operating profit margin calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Operating income 68 188 178 92 87 92 798 578 659 672 453 672 828 715 574 777 777 693 625 745 831 745
Net sales 2,585 2,375 2,603 2,487 2,475 2,403 4,472 4,197 4,154 3,848 4,368 3,774 3,669 3,448 3,753 3,477 3,572 3,388 3,594 3,479 3,536 3,284
Profitability Ratio
Operating profit margin1 5.23% 5.48% 4.50% 9.03% 11.48% 13.97% 16.24% 14.26% 15.21% 16.76% 17.48% 19.05% 20.17% 19.95% 19.88% 20.47% 20.24% 20.68% 21.20%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
Operating profit margin = 100 × (Operating incomeQ2 2016 + Operating incomeQ1 2016 + Operating incomeQ4 2015 + Operating incomeQ3 2015) ÷ (Net salesQ2 2016 + Net salesQ1 2016 + Net salesQ4 2015 + Net salesQ3 2015)
= 100 × (68 + 188 + 178 + 92) ÷ (2,585 + 2,375 + 2,603 + 2,487) = 5.23%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Baxter International Inc. operating profit margin ratio improved from Q4 2015 to Q1 2016 but then slightly deteriorated from Q1 2016 to Q2 2016.

Net Profit Margin

Baxter International Inc., net profit margin calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 1,212 3,380 205 1 332 430 953 468 520 556 326 544 590 552 494 583 661 588 463 576 615 570
Net sales 2,585 2,375 2,603 2,487 2,475 2,403 4,472 4,197 4,154 3,848 4,368 3,774 3,669 3,448 3,753 3,477 3,572 3,388 3,594 3,479 3,536 3,284
Profitability Ratio
Net profit margin1 47.74% 39.42% 9.71% 14.50% 16.11% 15.57% 14.98% 11.29% 12.05% 12.87% 13.19% 14.89% 15.47% 16.07% 16.39% 16.36% 16.30% 16.02% 16.01%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
Net profit margin = 100 × (Net income attributable to BaxterQ2 2016 + Net income attributable to BaxterQ1 2016 + Net income attributable to BaxterQ4 2015 + Net income attributable to BaxterQ3 2015) ÷ (Net salesQ2 2016 + Net salesQ1 2016 + Net salesQ4 2015 + Net salesQ3 2015)
= 100 × (1,212 + 3,380 + 205 + 1) ÷ (2,585 + 2,375 + 2,603 + 2,487) = 47.74%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Baxter International Inc. net profit margin ratio improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.

Return on Equity (ROE)

Baxter International Inc., ROE calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 1,212 3,380 205 1 332 430 953 468 520 556 326 544 590 552 494 583 661 588 463 576 615 570
Total Baxter shareholders’ equity 8,509 9,019 8,846 7,824 7,988 7,258 8,120 8,404 8,662 8,671 8,463 7,749 7,282 6,961 6,938 7,129 6,551 6,725 6,585 6,952 6,997 6,734
Profitability Ratio
ROE1 56.39% 43.44% 10.94% 21.93% 27.33% 32.67% 30.75% 22.25% 22.47% 23.25% 23.77% 28.13% 30.47% 32.90% 33.53% 32.19% 34.93% 33.34% 33.77%
Benchmarks
ROE, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
ROE = 100 × (Net income attributable to BaxterQ2 2016 + Net income attributable to BaxterQ1 2016 + Net income attributable to BaxterQ4 2015 + Net income attributable to BaxterQ3 2015) ÷ Total Baxter shareholders’ equity
= 100 × (1,212 + 3,380 + 205 + 1) ÷ 8,509 = 56.39%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Baxter International Inc. ROE improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.

Return on Assets (ROA)

Baxter International Inc., ROA calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 1,212 3,380 205 1 332 430 953 468 520 556 326 544 590 552 494 583 661 588 463 576 615 570
Total assets 15,982 17,350 20,975 20,172 30,015 24,861 25,917 25,563 25,629 25,261 25,869 25,250 23,751 20,318 20,390 19,825 18,446 18,784 19,073 17,843 17,741 17,413
Profitability Ratio
ROA1 30.02% 22.58% 4.62% 8.51% 7.27% 9.54% 9.63% 7.32% 7.59% 7.98% 7.78% 8.63% 9.34% 11.27% 11.41% 11.58% 12.40% 11.94% 11.66%
Benchmarks
ROA, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
ROA = 100 × (Net income attributable to BaxterQ2 2016 + Net income attributable to BaxterQ1 2016 + Net income attributable to BaxterQ4 2015 + Net income attributable to BaxterQ3 2015) ÷ Total assets
= 100 × (1,212 + 3,380 + 205 + 1) ÷ 15,982 = 30.02%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Baxter International Inc. ROA improved from Q4 2015 to Q1 2016 and from Q1 2016 to Q2 2016.